A global multiple ascending dose study of insulin tregopil in patients with type 1 diabetes.
Phase of Trial: Phase I
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Insulin tregopil (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Biocon
- 12 Sep 2017 New trial record
- 06 Sep 2017 According to a Biocon media release, the company announced a partnership with Juvenile Diabetes Research Foundation (JDRF) to support a global multiple ascending dose study.